ClinicalTrials.govpublic full text
Response-adapted Luvometinib With or Without Cytarabine in Langerhans Cell Histiocytosis
langerhans cell histiocytosis, lch, luvometinib, cytarabine, mek inhibitor, response-adapted therapy, pet/ct, cfdna, ctdna, mapk pathway, lucas, interventional
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 893877
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.